Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT00906516
Title Neuradiab Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bradmer Pharmaceuticals Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.